SPONSOR
Peking University Third Hospital
Total Trials
21
Recruiting
21
Phases
Phase 2, Phase 4
Conditions studied: Developmental Dysplasia of the HipMantle Cell Lymphoma (MCL)POZDegenerative Lumbar Spinal StenosisDegenerative Disc DiseaseDegeneration SpineRange of Motion, ArticularAdenomyosisIrreducible Atlantoaxial DislocationMigraine
Peking University Third Hospital is a clinical research sponsor with 21 registered studies on ClinicalTrials.gov, of which 21 are actively recruiting participants. Research covers conditions including Developmental Dysplasia of the Hip, Mantle Cell Lymphoma (MCL), POZ, Degenerative Lumbar Spinal Stenosis.
The trial portfolio spans Phase 2, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Peking University Third Hospital
How many clinical trials has Peking University Third Hospital sponsored?
ClinicalMetric currently tracks 21 clinical trials sponsored by Peking University Third Hospital, of which 21 are actively recruiting participants. These trials cover conditions including Developmental Dysplasia of the Hip, Mantle Cell Lymphoma (MCL), POZ. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Peking University Third Hospital research focus on?
Peking University Third Hospital clinical trials span Developmental Dysplasia of the Hip, Mantle Cell Lymphoma (MCL), POZ, Degenerative Lumbar Spinal Stenosis, Degenerative Disc Disease, and additional conditions. The research pipeline includes Phase 2, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Peking University Third Hospital clinical trial?
To participate in a Peking University Third Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Peking University Third Hospital trials with current recruitment status updated daily.
Clinical Trials by Peking University Third Hospital
NCT06512506
Recruiting
Prospective Cohort Study of Arthroscopic Treatment of Hip Dysplasia
Developmental Dysplasia of the Hip
NCT07257510
Recruiting
Pomalidomide Plus Orelabrutinib and Zuberitamab in Untreated Mantle Cell Lymphoma
Mantle Cell Lymphoma (MCL)
NCT04467944
Recruiting
Effect of Pre-existing Adjacent Segment Degeneration on Long-term Effectiveness After Lumbar Fusion Surgery
Degenerative Lumbar Spinal Stenosis
NCT07422714
Recruiting
Application of a Wearable Device-Based Intelligent Rehabilitation System in the Rehabilitation of Patients With Frozen Shoulder
Range of Motion, Articular
NCT06123975
Recruiting
Adenomyosis Patients With Infertility and Immunological Factors
Adenomyosis
NCT05847270
Recruiting
Surgical Treatment of Irreducible Atlantoaxial Dislocation
Irreducible Atlantoaxial Dislocation
NCT06953622
Recruiting
Establishment of a Clinical and Prognostic Follow-up Cohort of Migraine Patients With Patent Foramen Ovale
Migraine
NCT06368544
Recruiting
Effect of Early Gait Training on Knee Cartilage Degeneration After Anterior Cruciate Ligament Reconstruction
Anterior Cruciate Ligament Injuries
NCT06897293
Recruiting
Comparison of MBR + Suture Tape and MBR for CLAI : A Prospective Cohort Study
Ankle Sprain
NCT06794047
Recruiting
The Effect of VitC on IVF Outcome of DOR Patients
Diminished Ovarian Reserve
NCT07306221
Recruiting
Effect of Visual-Guided Balance Training on Knee Motor Function and Biomechanical Characteristics After ACL Reconstruction
Anterior Cruciate Ligament Injuries
NCT04163133
Recruiting
Trigger Timing in Ovarian Stimulations
IVF Outcome
NCT05402839
Recruiting
Screening of Malignant Hyperthermia Susceptible Individuals
Malignant Hyperthermia
NCT06277531
Recruiting
Evaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE)
Biliary Stricture
NCT06621056
Recruiting
A Cohort Study of Risk Factors and Prognosis for Frequent Acute Asthma Exacerbations Phenotype
Asthma Exacerbations
NCT04834544 Phase 2
Recruiting
A Study of Maintenance DCVAC/OvCa After First-line Chemotherapy Added Standard of Care
Epithelial Ovarian Carcinoma
NCT07423767
Recruiting
Effects of a Preoperative Cognitive-Behavioral Intervention on Kinesiophobia and Function in Anterior Cruciate Ligament Reconstruction
Anterior Cruciate Ligament (ACL) Tear
NCT06587009
Recruiting
Application of Shock Wave Technique in Conservative Treatment of Rotator Cuff Tear
Rotator Cuff Tear
NCT06564428
Recruiting
A Cohort Study of Hereditary Ovarian Cancer Risk Prediction Models and Pathogenesis Exploration
Ovarian Neoplasms
NCT06349629
Recruiting
The Clinical Study of 3D-printed Magnesium Alloy Prosthesis With Controllable Degradation Rate in the Repair of Periarticular Bone Defects
Degradation of Magnesium Alloy Prosthesis and New Bone Regeneration
NCT06546540 Phase 4
Recruiting
The Safety and Efficacy of Telitacicept in the Treatment of Systemic Sclerosis
Systemic Sclerosis
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology